ZELTIQ Aesthetics (CoolSculpting)

ZELTIQ® is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ’s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably and measurably reduce the fat layer.
Pleasanton, US
535 (est)+32%

Key People at ZELTIQ Aesthetics (CoolSculpting)

Sergio Garcia

Sergio Garcia

Senior Vice President, General Counsel and Secretary
Patrick F. Williams

Patrick F. Williams

Senior Vice President and Chief Financial Officer
Keith Sullivan

Keith Sullivan

Senior Vice President of Worldwide Sales
Kristine N. Tatsutani

Kristine N. Tatsutani

Chief Scientific Officer and Senior Vice President of Clinical, Regulatory and Quality
Carl Lamm

Carl Lamm

Vice President of Operations

ZELTIQ Aesthetics (CoolSculpting) Locations

Pleasanton, US
Boston, US
Santiago de Compostela, ES
Zürich, CH
Shanghai, CN
Beijing, CN
Munich, DE
Taipei, TW
Kuala Lumpur, MY
Dublin, IE
Seattle, US
New Orleans, US
Brussels, BE
Pittsburgh, US
Paris, FR
Reston, US
Atlanta, US
Moscow, RU
Houston, US

ZELTIQ Aesthetics (CoolSculpting) Metrics

ZELTIQ Aesthetics (CoolSculpting) Summary

Founding Date


Market capitalization

$1.39 B

Closing share price


ZELTIQ Aesthetics (CoolSculpting) Market Value History

ZELTIQ Aesthetics (CoolSculpting) Online Presence

ZELTIQ Aesthetics (CoolSculpting) Company Life